Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gevers

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|February 8, 2024
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver diseaseLorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Nephron|September 7, 2016
International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst InfectionMarten A Lantinga, Alexander J M Darding, Ruud G L de Sévaux, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2024
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision frameworkRenée Duijzer, Lucas H P Bernts, Anja Geerts, et al.
Trials|January 17, 2024
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trialAnna E C Stoelinga, Maarten E Tushuizen, Wilbert B van den Hout, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre StudyNatalie Uhlenbusch, Romée J A L M Snijders, Meike Mund, et al.
Journal of Hepatology|December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitisRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials|December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trialRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitisDonald Malino, Greta Codoni, Theresa Kirchner, et al.
Gastroenterology|October 16, 2024
Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype)Malin Fromme, Audrey Payancé, Mattias Mandorfer, et al.
The American Journal of Gastroenterology|December 9, 2025
Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world studyMaria C van Hooff, Rozanne C de Veer, Ellen Werner, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|February 8, 2024
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver diseaseLorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Nephron|September 7, 2016
International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst InfectionMarten A Lantinga, Alexander J M Darding, Ruud G L de Sévaux, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2024
Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision frameworkRenée Duijzer, Lucas H P Bernts, Anja Geerts, et al.
Trials|January 17, 2024
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trialAnna E C Stoelinga, Maarten E Tushuizen, Wilbert B van den Hout, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre StudyNatalie Uhlenbusch, Romée J A L M Snijders, Meike Mund, et al.
Journal of Hepatology|December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitisRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials|December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trialRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2026
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitisDonald Malino, Greta Codoni, Theresa Kirchner, et al.
Gastroenterology|October 16, 2024
Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype)Malin Fromme, Audrey Payancé, Mattias Mandorfer, et al.
The American Journal of Gastroenterology|December 9, 2025
Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world studyMaria C van Hooff, Rozanne C de Veer, Ellen Werner, et al.
Pageof 10